Welcome to our dedicated page for Pennant Group SEC filings (Ticker: PNTG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Pennant Group, Inc. (NASDAQ: PNTG) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as a public Delaware corporation. Pennant is the holding company for independent operating subsidiaries that provide home health, hospice, home care and senior living services across multiple states, and its filings offer detailed insight into this structure and its financial results.
Users can review current reports on Form 8-K in which Pennant describes material events such as acquisitions, credit facility amendments and quarterly earnings releases. For example, the company has filed 8-Ks covering its Amended and Restated Credit Agreement and a First Amendment that added an incremental term loan facility, as well as 8-Ks documenting the completion of acquisitions from UnitedHealth Group and Amedisys related to home health, hospice and palliative care operations.
Amended 8-K filings (8-K/A) on this page include additional information required by SEC rules, such as audited and unaudited abbreviated financial statements of acquired businesses and unaudited pro forma condensed combined financial statements. These documents help readers understand how significant acquisitions may affect Pennant’s financial position and results.
In addition to event-driven filings, investors can access Pennant’s periodic reports on Forms 10-K and 10-Q, which contain full financial statements, segment disclosures for home health and hospice services and senior living services, and discussions of risk factors and non-GAAP metrics. The platform also surfaces filings related to earnings announcements, where Pennant furnishes press releases under Item 2.02 and provides Regulation FD disclosures under Item 7.01.
Stock Titan enhances these documents with AI-powered summaries that explain key sections of lengthy filings, highlight important items such as acquisition terms, credit facility covenants and segment performance, and help readers quickly identify the most relevant information in Pennant’s regulatory history.